The present invention provides stable pre-fusion respiratory syncitial virus (RSV) F polypeptides, immunogenic compositions comprising said polypeptides and uses thereof for the prevention and/or treatment of RSV infection.LA INVENCIÓN PROPORCIONA POLIPÉPTIDOS F DE PREFUSIÓN DEL VIRUS SINCICIAL RESPIRATORIO RSV SOLUBLES Y ESTABILIZADOS